The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Krystal Biotech, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2023 to Q4 2024.
Krystal Biotech, Inc. Operating Margin for the quarter ending December 31, 2024 was 22.6 %.
Krystal Biotech, Inc. annual Operating Margin for 2024 was 22.6 %.
Operating Margin, Quarterly (%)
Period
Value
YoY Chg
Change %
Start Date
End Date
Q4 2024
22.6
+239
Oct 1, 2024
Dec 31, 2024
Q3 2024
11.4
Jul 1, 2024
Sep 30, 2024
Q2 2024
-12.6
Apr 1, 2024
Jun 30, 2024
Q1 2024
-70.4
Jan 1, 2024
Mar 31, 2024
Q4 2023
-216
Oct 1, 2023
Dec 31, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.